Global Human Serum and Plasma Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Human Serum and Plasma market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Human plasma is an important component of blood. It is a liquid without cell components obtained by centrifugation after the whole blood leaves the blood vessels and is anticoagulated. Human serum refers to the light yellow transparent liquid separated from the plasma by removing fibrinogen after blood coagulation, or plasma without fibrinogen. It is an invisible component of blood and is different from plasma in composition.
This report is a detailed and comprehensive analysis for global Human Serum and Plasma market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Human Serum and Plasma market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Human Serum and Plasma market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Human Serum and Plasma market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Human Serum and Plasma market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Serum and Plasma
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Serum and Plasma market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Akron, Baxter, Cytiva, Merck Millipore, Monobind, SeraCare, TCS Biosciences Ltd, Thermo Fisher, Trina Bioreactives, Zen-Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Human Serum and Plasma market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Serum and Plasma product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Serum and Plasma, with price, sales quantity, revenue, and global market share of Human Serum and Plasma from 2020 to 2025.
Chapter 3, the Human Serum and Plasma competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Serum and Plasma breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Human Serum and Plasma market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Serum and Plasma.
Chapter 14 and 15, to describe Human Serum and Plasma sales channel, distributors, customers, research findings and conclusion.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
Human plasma is an important component of blood. It is a liquid without cell components obtained by centrifugation after the whole blood leaves the blood vessels and is anticoagulated. Human serum refers to the light yellow transparent liquid separated from the plasma by removing fibrinogen after blood coagulation, or plasma without fibrinogen. It is an invisible component of blood and is different from plasma in composition.
This report is a detailed and comprehensive analysis for global Human Serum and Plasma market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Human Serum and Plasma market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Human Serum and Plasma market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Human Serum and Plasma market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Human Serum and Plasma market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Human Serum and Plasma
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Human Serum and Plasma market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Akron, Baxter, Cytiva, Merck Millipore, Monobind, SeraCare, TCS Biosciences Ltd, Thermo Fisher, Trina Bioreactives, Zen-Bio, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Human Serum and Plasma market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Fresh Human Serum and Plasma
- Frozen Human Serum and Plasma
- In Vitro Diagnostics
- Vaccines and Antibodies
- Cell Culture
- Clinical Research
- Others
- Akron
- Baxter
- Cytiva
- Merck Millipore
- Monobind
- SeraCare
- TCS Biosciences Ltd
- Thermo Fisher
- Trina Bioreactives
- Zen-Bio
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Serum and Plasma product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Human Serum and Plasma, with price, sales quantity, revenue, and global market share of Human Serum and Plasma from 2020 to 2025.
Chapter 3, the Human Serum and Plasma competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Serum and Plasma breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Human Serum and Plasma market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Human Serum and Plasma.
Chapter 14 and 15, to describe Human Serum and Plasma sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Serum and Plasma Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Fresh Human Serum and Plasma
1.3.3 Frozen Human Serum and Plasma
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Serum and Plasma Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 In Vitro Diagnostics
1.4.3 Vaccines and Antibodies
1.4.4 Cell Culture
1.4.5 Clinical Research
1.4.6 Others
1.5 Global Human Serum and Plasma Market Size & Forecast
1.5.1 Global Human Serum and Plasma Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Human Serum and Plasma Sales Quantity (2020-2031)
1.5.3 Global Human Serum and Plasma Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Akron
2.1.1 Akron Details
2.1.2 Akron Major Business
2.1.3 Akron Human Serum and Plasma Product and Services
2.1.4 Akron Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Akron Recent Developments/Updates
2.2 Baxter
2.2.1 Baxter Details
2.2.2 Baxter Major Business
2.2.3 Baxter Human Serum and Plasma Product and Services
2.2.4 Baxter Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Baxter Recent Developments/Updates
2.3 Cytiva
2.3.1 Cytiva Details
2.3.2 Cytiva Major Business
2.3.3 Cytiva Human Serum and Plasma Product and Services
2.3.4 Cytiva Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Cytiva Recent Developments/Updates
2.4 Merck Millipore
2.4.1 Merck Millipore Details
2.4.2 Merck Millipore Major Business
2.4.3 Merck Millipore Human Serum and Plasma Product and Services
2.4.4 Merck Millipore Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Merck Millipore Recent Developments/Updates
2.5 Monobind
2.5.1 Monobind Details
2.5.2 Monobind Major Business
2.5.3 Monobind Human Serum and Plasma Product and Services
2.5.4 Monobind Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Monobind Recent Developments/Updates
2.6 SeraCare
2.6.1 SeraCare Details
2.6.2 SeraCare Major Business
2.6.3 SeraCare Human Serum and Plasma Product and Services
2.6.4 SeraCare Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 SeraCare Recent Developments/Updates
2.7 TCS Biosciences Ltd
2.7.1 TCS Biosciences Ltd Details
2.7.2 TCS Biosciences Ltd Major Business
2.7.3 TCS Biosciences Ltd Human Serum and Plasma Product and Services
2.7.4 TCS Biosciences Ltd Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 TCS Biosciences Ltd Recent Developments/Updates
2.8 Thermo Fisher
2.8.1 Thermo Fisher Details
2.8.2 Thermo Fisher Major Business
2.8.3 Thermo Fisher Human Serum and Plasma Product and Services
2.8.4 Thermo Fisher Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Thermo Fisher Recent Developments/Updates
2.9 Trina Bioreactives
2.9.1 Trina Bioreactives Details
2.9.2 Trina Bioreactives Major Business
2.9.3 Trina Bioreactives Human Serum and Plasma Product and Services
2.9.4 Trina Bioreactives Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Trina Bioreactives Recent Developments/Updates
2.10 Zen-Bio
2.10.1 Zen-Bio Details
2.10.2 Zen-Bio Major Business
2.10.3 Zen-Bio Human Serum and Plasma Product and Services
2.10.4 Zen-Bio Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Zen-Bio Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HUMAN SERUM AND PLASMA BY MANUFACTURER
3.1 Global Human Serum and Plasma Sales Quantity by Manufacturer (2020-2025)
3.2 Global Human Serum and Plasma Revenue by Manufacturer (2020-2025)
3.3 Global Human Serum and Plasma Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Human Serum and Plasma by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Human Serum and Plasma Manufacturer Market Share in 2024
3.4.3 Top 6 Human Serum and Plasma Manufacturer Market Share in 2024
3.5 Human Serum and Plasma Market: Overall Company Footprint Analysis
3.5.1 Human Serum and Plasma Market: Region Footprint
3.5.2 Human Serum and Plasma Market: Company Product Type Footprint
3.5.3 Human Serum and Plasma Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Human Serum and Plasma Market Size by Region
4.1.1 Global Human Serum and Plasma Sales Quantity by Region (2020-2031)
4.1.2 Global Human Serum and Plasma Consumption Value by Region (2020-2031)
4.1.3 Global Human Serum and Plasma Average Price by Region (2020-2031)
4.2 North America Human Serum and Plasma Consumption Value (2020-2031)
4.3 Europe Human Serum and Plasma Consumption Value (2020-2031)
4.4 Asia-Pacific Human Serum and Plasma Consumption Value (2020-2031)
4.5 South America Human Serum and Plasma Consumption Value (2020-2031)
4.6 Middle East & Africa Human Serum and Plasma Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Human Serum and Plasma Sales Quantity by Type (2020-2031)
5.2 Global Human Serum and Plasma Consumption Value by Type (2020-2031)
5.3 Global Human Serum and Plasma Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Human Serum and Plasma Sales Quantity by Application (2020-2031)
6.2 Global Human Serum and Plasma Consumption Value by Application (2020-2031)
6.3 Global Human Serum and Plasma Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Human Serum and Plasma Sales Quantity by Type (2020-2031)
7.2 North America Human Serum and Plasma Sales Quantity by Application (2020-2031)
7.3 North America Human Serum and Plasma Market Size by Country
7.3.1 North America Human Serum and Plasma Sales Quantity by Country (2020-2031)
7.3.2 North America Human Serum and Plasma Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Human Serum and Plasma Sales Quantity by Type (2020-2031)
8.2 Europe Human Serum and Plasma Sales Quantity by Application (2020-2031)
8.3 Europe Human Serum and Plasma Market Size by Country
8.3.1 Europe Human Serum and Plasma Sales Quantity by Country (2020-2031)
8.3.2 Europe Human Serum and Plasma Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Human Serum and Plasma Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Human Serum and Plasma Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Human Serum and Plasma Market Size by Region
9.3.1 Asia-Pacific Human Serum and Plasma Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Human Serum and Plasma Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Human Serum and Plasma Sales Quantity by Type (2020-2031)
10.2 South America Human Serum and Plasma Sales Quantity by Application (2020-2031)
10.3 South America Human Serum and Plasma Market Size by Country
10.3.1 South America Human Serum and Plasma Sales Quantity by Country (2020-2031)
10.3.2 South America Human Serum and Plasma Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Human Serum and Plasma Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Human Serum and Plasma Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Human Serum and Plasma Market Size by Country
11.3.1 Middle East & Africa Human Serum and Plasma Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Human Serum and Plasma Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Human Serum and Plasma Market Drivers
12.2 Human Serum and Plasma Market Restraints
12.3 Human Serum and Plasma Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Human Serum and Plasma and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Serum and Plasma
13.3 Human Serum and Plasma Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Serum and Plasma Typical Distributors
14.3 Human Serum and Plasma Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Human Serum and Plasma Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Fresh Human Serum and Plasma
1.3.3 Frozen Human Serum and Plasma
1.4 Market Analysis by Application
1.4.1 Overview: Global Human Serum and Plasma Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 In Vitro Diagnostics
1.4.3 Vaccines and Antibodies
1.4.4 Cell Culture
1.4.5 Clinical Research
1.4.6 Others
1.5 Global Human Serum and Plasma Market Size & Forecast
1.5.1 Global Human Serum and Plasma Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Human Serum and Plasma Sales Quantity (2020-2031)
1.5.3 Global Human Serum and Plasma Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 Akron
2.1.1 Akron Details
2.1.2 Akron Major Business
2.1.3 Akron Human Serum and Plasma Product and Services
2.1.4 Akron Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Akron Recent Developments/Updates
2.2 Baxter
2.2.1 Baxter Details
2.2.2 Baxter Major Business
2.2.3 Baxter Human Serum and Plasma Product and Services
2.2.4 Baxter Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Baxter Recent Developments/Updates
2.3 Cytiva
2.3.1 Cytiva Details
2.3.2 Cytiva Major Business
2.3.3 Cytiva Human Serum and Plasma Product and Services
2.3.4 Cytiva Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Cytiva Recent Developments/Updates
2.4 Merck Millipore
2.4.1 Merck Millipore Details
2.4.2 Merck Millipore Major Business
2.4.3 Merck Millipore Human Serum and Plasma Product and Services
2.4.4 Merck Millipore Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Merck Millipore Recent Developments/Updates
2.5 Monobind
2.5.1 Monobind Details
2.5.2 Monobind Major Business
2.5.3 Monobind Human Serum and Plasma Product and Services
2.5.4 Monobind Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Monobind Recent Developments/Updates
2.6 SeraCare
2.6.1 SeraCare Details
2.6.2 SeraCare Major Business
2.6.3 SeraCare Human Serum and Plasma Product and Services
2.6.4 SeraCare Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 SeraCare Recent Developments/Updates
2.7 TCS Biosciences Ltd
2.7.1 TCS Biosciences Ltd Details
2.7.2 TCS Biosciences Ltd Major Business
2.7.3 TCS Biosciences Ltd Human Serum and Plasma Product and Services
2.7.4 TCS Biosciences Ltd Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 TCS Biosciences Ltd Recent Developments/Updates
2.8 Thermo Fisher
2.8.1 Thermo Fisher Details
2.8.2 Thermo Fisher Major Business
2.8.3 Thermo Fisher Human Serum and Plasma Product and Services
2.8.4 Thermo Fisher Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Thermo Fisher Recent Developments/Updates
2.9 Trina Bioreactives
2.9.1 Trina Bioreactives Details
2.9.2 Trina Bioreactives Major Business
2.9.3 Trina Bioreactives Human Serum and Plasma Product and Services
2.9.4 Trina Bioreactives Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Trina Bioreactives Recent Developments/Updates
2.10 Zen-Bio
2.10.1 Zen-Bio Details
2.10.2 Zen-Bio Major Business
2.10.3 Zen-Bio Human Serum and Plasma Product and Services
2.10.4 Zen-Bio Human Serum and Plasma Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Zen-Bio Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: HUMAN SERUM AND PLASMA BY MANUFACTURER
3.1 Global Human Serum and Plasma Sales Quantity by Manufacturer (2020-2025)
3.2 Global Human Serum and Plasma Revenue by Manufacturer (2020-2025)
3.3 Global Human Serum and Plasma Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Human Serum and Plasma by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Human Serum and Plasma Manufacturer Market Share in 2024
3.4.3 Top 6 Human Serum and Plasma Manufacturer Market Share in 2024
3.5 Human Serum and Plasma Market: Overall Company Footprint Analysis
3.5.1 Human Serum and Plasma Market: Region Footprint
3.5.2 Human Serum and Plasma Market: Company Product Type Footprint
3.5.3 Human Serum and Plasma Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Human Serum and Plasma Market Size by Region
4.1.1 Global Human Serum and Plasma Sales Quantity by Region (2020-2031)
4.1.2 Global Human Serum and Plasma Consumption Value by Region (2020-2031)
4.1.3 Global Human Serum and Plasma Average Price by Region (2020-2031)
4.2 North America Human Serum and Plasma Consumption Value (2020-2031)
4.3 Europe Human Serum and Plasma Consumption Value (2020-2031)
4.4 Asia-Pacific Human Serum and Plasma Consumption Value (2020-2031)
4.5 South America Human Serum and Plasma Consumption Value (2020-2031)
4.6 Middle East & Africa Human Serum and Plasma Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Human Serum and Plasma Sales Quantity by Type (2020-2031)
5.2 Global Human Serum and Plasma Consumption Value by Type (2020-2031)
5.3 Global Human Serum and Plasma Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Human Serum and Plasma Sales Quantity by Application (2020-2031)
6.2 Global Human Serum and Plasma Consumption Value by Application (2020-2031)
6.3 Global Human Serum and Plasma Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Human Serum and Plasma Sales Quantity by Type (2020-2031)
7.2 North America Human Serum and Plasma Sales Quantity by Application (2020-2031)
7.3 North America Human Serum and Plasma Market Size by Country
7.3.1 North America Human Serum and Plasma Sales Quantity by Country (2020-2031)
7.3.2 North America Human Serum and Plasma Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Human Serum and Plasma Sales Quantity by Type (2020-2031)
8.2 Europe Human Serum and Plasma Sales Quantity by Application (2020-2031)
8.3 Europe Human Serum and Plasma Market Size by Country
8.3.1 Europe Human Serum and Plasma Sales Quantity by Country (2020-2031)
8.3.2 Europe Human Serum and Plasma Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Human Serum and Plasma Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Human Serum and Plasma Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Human Serum and Plasma Market Size by Region
9.3.1 Asia-Pacific Human Serum and Plasma Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Human Serum and Plasma Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Human Serum and Plasma Sales Quantity by Type (2020-2031)
10.2 South America Human Serum and Plasma Sales Quantity by Application (2020-2031)
10.3 South America Human Serum and Plasma Market Size by Country
10.3.1 South America Human Serum and Plasma Sales Quantity by Country (2020-2031)
10.3.2 South America Human Serum and Plasma Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Human Serum and Plasma Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Human Serum and Plasma Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Human Serum and Plasma Market Size by Country
11.3.1 Middle East & Africa Human Serum and Plasma Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Human Serum and Plasma Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Human Serum and Plasma Market Drivers
12.2 Human Serum and Plasma Market Restraints
12.3 Human Serum and Plasma Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Human Serum and Plasma and Key Manufacturers
13.2 Manufacturing Costs Percentage of Human Serum and Plasma
13.3 Human Serum and Plasma Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Human Serum and Plasma Typical Distributors
14.3 Human Serum and Plasma Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Human Serum and Plasma Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Human Serum and Plasma Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Akron Basic Information, Manufacturing Base and Competitors
Table 4. Akron Major Business
Table 5. Akron Human Serum and Plasma Product and Services
Table 6. Akron Human Serum and Plasma Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Akron Recent Developments/Updates
Table 8. Baxter Basic Information, Manufacturing Base and Competitors
Table 9. Baxter Major Business
Table 10. Baxter Human Serum and Plasma Product and Services
Table 11. Baxter Human Serum and Plasma Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Baxter Recent Developments/Updates
Table 13. Cytiva Basic Information, Manufacturing Base and Competitors
Table 14. Cytiva Major Business
Table 15. Cytiva Human Serum and Plasma Product and Services
Table 16. Cytiva Human Serum and Plasma Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Cytiva Recent Developments/Updates
Table 18. Merck Millipore Basic Information, Manufacturing Base and Competitors
Table 19. Merck Millipore Major Business
Table 20. Merck Millipore Human Serum and Plasma Product and Services
Table 21. Merck Millipore Human Serum and Plasma Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Merck Millipore Recent Developments/Updates
Table 23. Monobind Basic Information, Manufacturing Base and Competitors
Table 24. Monobind Major Business
Table 25. Monobind Human Serum and Plasma Product and Services
Table 26. Monobind Human Serum and Plasma Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Monobind Recent Developments/Updates
Table 28. SeraCare Basic Information, Manufacturing Base and Competitors
Table 29. SeraCare Major Business
Table 30. SeraCare Human Serum and Plasma Product and Services
Table 31. SeraCare Human Serum and Plasma Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. SeraCare Recent Developments/Updates
Table 33. TCS Biosciences Ltd Basic Information, Manufacturing Base and Competitors
Table 34. TCS Biosciences Ltd Major Business
Table 35. TCS Biosciences Ltd Human Serum and Plasma Product and Services
Table 36. TCS Biosciences Ltd Human Serum and Plasma Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. TCS Biosciences Ltd Recent Developments/Updates
Table 38. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 39. Thermo Fisher Major Business
Table 40. Thermo Fisher Human Serum and Plasma Product and Services
Table 41. Thermo Fisher Human Serum and Plasma Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Thermo Fisher Recent Developments/Updates
Table 43. Trina Bioreactives Basic Information, Manufacturing Base and Competitors
Table 44. Trina Bioreactives Major Business
Table 45. Trina Bioreactives Human Serum and Plasma Product and Services
Table 46. Trina Bioreactives Human Serum and Plasma Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Trina Bioreactives Recent Developments/Updates
Table 48. Zen-Bio Basic Information, Manufacturing Base and Competitors
Table 49. Zen-Bio Major Business
Table 50. Zen-Bio Human Serum and Plasma Product and Services
Table 51. Zen-Bio Human Serum and Plasma Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Zen-Bio Recent Developments/Updates
Table 53. Global Human Serum and Plasma Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 54. Global Human Serum and Plasma Revenue by Manufacturer (2020-2025) & (USD Million)
Table 55. Global Human Serum and Plasma Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 56. Market Position of Manufacturers in Human Serum and Plasma, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 57. Head Office and Human Serum and Plasma Production Site of Key Manufacturer
Table 58. Human Serum and Plasma Market: Company Product Type Footprint
Table 59. Human Serum and Plasma Market: Company Product Application Footprint
Table 60. Human Serum and Plasma New Market Entrants and Barriers to Market Entry
Table 61. Human Serum and Plasma Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Human Serum and Plasma Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 63. Global Human Serum and Plasma Sales Quantity by Region (2020-2025) & (K Units)
Table 64. Global Human Serum and Plasma Sales Quantity by Region (2026-2031) & (K Units)
Table 65. Global Human Serum and Plasma Consumption Value by Region (2020-2025) & (USD Million)
Table 66. Global Human Serum and Plasma Consumption Value by Region (2026-2031) & (USD Million)
Table 67. Global Human Serum and Plasma Average Price by Region (2020-2025) & (US$/Unit)
Table 68. Global Human Serum and Plasma Average Price by Region (2026-2031) & (US$/Unit)
Table 69. Global Human Serum and Plasma Sales Quantity by Type (2020-2025) & (K Units)
Table 70. Global Human Serum and Plasma Sales Quantity by Type (2026-2031) & (K Units)
Table 71. Global Human Serum and Plasma Consumption Value by Type (2020-2025) & (USD Million)
Table 72. Global Human Serum and Plasma Consumption Value by Type (2026-2031) & (USD Million)
Table 73. Global Human Serum and Plasma Average Price by Type (2020-2025) & (US$/Unit)
Table 74. Global Human Serum and Plasma Average Price by Type (2026-2031) & (US$/Unit)
Table 75. Global Human Serum and Plasma Sales Quantity by Application (2020-2025) & (K Units)
Table 76. Global Human Serum and Plasma Sales Quantity by Application (2026-2031) & (K Units)
Table 77. Global Human Serum and Plasma Consumption Value by Application (2020-2025) & (USD Million)
Table 78. Global Human Serum and Plasma Consumption Value by Application (2026-2031) & (USD Million)
Table 79. Global Human Serum and Plasma Average Price by Application (2020-2025) & (US$/Unit)
Table 80. Global Human Serum and Plasma Average Price by Application (2026-2031) & (US$/Unit)
Table 81. North America Human Serum and Plasma Sales Quantity by Type (2020-2025) & (K Units)
Table 82. North America Human Serum and Plasma Sales Quantity by Type (2026-2031) & (K Units)
Table 83. North America Human Serum and Plasma Sales Quantity by Application (2020-2025) & (K Units)
Table 84. North America Human Serum and Plasma Sales Quantity by Application (2026-2031) & (K Units)
Table 85. North America Human Serum and Plasma Sales Quantity by Country (2020-2025) & (K Units)
Table 86. North America Human Serum and Plasma Sales Quantity by Country (2026-2031) & (K Units)
Table 87. North America Human Serum and Plasma Consumption Value by Country (2020-2025) & (USD Million)
Table 88. North America Human Serum and Plasma Consumption Value by Country (2026-2031) & (USD Million)
Table 89. Europe Human Serum and Plasma Sales Quantity by Type (2020-2025) & (K Units)
Table 90. Europe Human Serum and Plasma Sales Quantity by Type (2026-2031) & (K Units)
Table 91. Europe Human Serum and Plasma Sales Quantity by Application (2020-2025) & (K Units)
Table 92. Europe Human Serum and Plasma Sales Quantity by Application (2026-2031) & (K Units)
Table 93. Europe Human Serum and Plasma Sales Quantity by Country (2020-2025) & (K Units)
Table 94. Europe Human Serum and Plasma Sales Quantity by Country (2026-2031) & (K Units)
Table 95. Europe Human Serum and Plasma Consumption Value by Country (2020-2025) & (USD Million)
Table 96. Europe Human Serum and Plasma Consumption Value by Country (2026-2031) & (USD Million)
Table 97. Asia-Pacific Human Serum and Plasma Sales Quantity by Type (2020-2025) & (K Units)
Table 98. Asia-Pacific Human Serum and Plasma Sales Quantity by Type (2026-2031) & (K Units)
Table 99. Asia-Pacific Human Serum and Plasma Sales Quantity by Application (2020-2025) & (K Units)
Table 100. Asia-Pacific Human Serum and Plasma Sales Quantity by Application (2026-2031) & (K Units)
Table 101. Asia-Pacific Human Serum and Plasma Sales Quantity by Region (2020-2025) & (K Units)
Table 102. Asia-Pacific Human Serum and Plasma Sales Quantity by Region (2026-2031) & (K Units)
Table 103. Asia-Pacific Human Serum and Plasma Consumption Value by Region (2020-2025) & (USD Million)
Table 104. Asia-Pacific Human Serum and Plasma Consumption Value by Region (2026-2031) & (USD Million)
Table 105. South America Human Serum and Plasma Sales Quantity by Type (2020-2025) & (K Units)
Table 106. South America Human Serum and Plasma Sales Quantity by Type (2026-2031) & (K Units)
Table 107. South America Human Serum and Plasma Sales Quantity by Application (2020-2025) & (K Units)
Table 108. South America Human Serum and Plasma Sales Quantity by Application (2026-2031) & (K Units)
Table 109. South America Human Serum and Plasma Sales Quantity by Country (2020-2025) & (K Units)
Table 110. South America Human Serum and Plasma Sales Quantity by Country (2026-2031) & (K Units)
Table 111. South America Human Serum and Plasma Consumption Value by Country (2020-2025) & (USD Million)
Table 112. South America Human Serum and Plasma Consumption Value by Country (2026-2031) & (USD Million)
Table 113. Middle East & Africa Human Serum and Plasma Sales Quantity by Type (2020-2025) & (K Units)
Table 114. Middle East & Africa Human Serum and Plasma Sales Quantity by Type (2026-2031) & (K Units)
Table 115. Middle East & Africa Human Serum and Plasma Sales Quantity by Application (2020-2025) & (K Units)
Table 116. Middle East & Africa Human Serum and Plasma Sales Quantity by Application (2026-2031) & (K Units)
Table 117. Middle East & Africa Human Serum and Plasma Sales Quantity by Country (2020-2025) & (K Units)
Table 118. Middle East & Africa Human Serum and Plasma Sales Quantity by Country (2026-2031) & (K Units)
Table 119. Middle East & Africa Human Serum and Plasma Consumption Value by Country (2020-2025) & (USD Million)
Table 120. Middle East & Africa Human Serum and Plasma Consumption Value by Country (2026-2031) & (USD Million)
Table 121. Human Serum and Plasma Raw Material
Table 122. Key Manufacturers of Human Serum and Plasma Raw Materials
Table 123. Human Serum and Plasma Typical Distributors
Table 124. Human Serum and Plasma Typical Customers
Table 1. Global Human Serum and Plasma Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Human Serum and Plasma Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Akron Basic Information, Manufacturing Base and Competitors
Table 4. Akron Major Business
Table 5. Akron Human Serum and Plasma Product and Services
Table 6. Akron Human Serum and Plasma Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Akron Recent Developments/Updates
Table 8. Baxter Basic Information, Manufacturing Base and Competitors
Table 9. Baxter Major Business
Table 10. Baxter Human Serum and Plasma Product and Services
Table 11. Baxter Human Serum and Plasma Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Baxter Recent Developments/Updates
Table 13. Cytiva Basic Information, Manufacturing Base and Competitors
Table 14. Cytiva Major Business
Table 15. Cytiva Human Serum and Plasma Product and Services
Table 16. Cytiva Human Serum and Plasma Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Cytiva Recent Developments/Updates
Table 18. Merck Millipore Basic Information, Manufacturing Base and Competitors
Table 19. Merck Millipore Major Business
Table 20. Merck Millipore Human Serum and Plasma Product and Services
Table 21. Merck Millipore Human Serum and Plasma Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Merck Millipore Recent Developments/Updates
Table 23. Monobind Basic Information, Manufacturing Base and Competitors
Table 24. Monobind Major Business
Table 25. Monobind Human Serum and Plasma Product and Services
Table 26. Monobind Human Serum and Plasma Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Monobind Recent Developments/Updates
Table 28. SeraCare Basic Information, Manufacturing Base and Competitors
Table 29. SeraCare Major Business
Table 30. SeraCare Human Serum and Plasma Product and Services
Table 31. SeraCare Human Serum and Plasma Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. SeraCare Recent Developments/Updates
Table 33. TCS Biosciences Ltd Basic Information, Manufacturing Base and Competitors
Table 34. TCS Biosciences Ltd Major Business
Table 35. TCS Biosciences Ltd Human Serum and Plasma Product and Services
Table 36. TCS Biosciences Ltd Human Serum and Plasma Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. TCS Biosciences Ltd Recent Developments/Updates
Table 38. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 39. Thermo Fisher Major Business
Table 40. Thermo Fisher Human Serum and Plasma Product and Services
Table 41. Thermo Fisher Human Serum and Plasma Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Thermo Fisher Recent Developments/Updates
Table 43. Trina Bioreactives Basic Information, Manufacturing Base and Competitors
Table 44. Trina Bioreactives Major Business
Table 45. Trina Bioreactives Human Serum and Plasma Product and Services
Table 46. Trina Bioreactives Human Serum and Plasma Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Trina Bioreactives Recent Developments/Updates
Table 48. Zen-Bio Basic Information, Manufacturing Base and Competitors
Table 49. Zen-Bio Major Business
Table 50. Zen-Bio Human Serum and Plasma Product and Services
Table 51. Zen-Bio Human Serum and Plasma Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Zen-Bio Recent Developments/Updates
Table 53. Global Human Serum and Plasma Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 54. Global Human Serum and Plasma Revenue by Manufacturer (2020-2025) & (USD Million)
Table 55. Global Human Serum and Plasma Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 56. Market Position of Manufacturers in Human Serum and Plasma, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 57. Head Office and Human Serum and Plasma Production Site of Key Manufacturer
Table 58. Human Serum and Plasma Market: Company Product Type Footprint
Table 59. Human Serum and Plasma Market: Company Product Application Footprint
Table 60. Human Serum and Plasma New Market Entrants and Barriers to Market Entry
Table 61. Human Serum and Plasma Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Human Serum and Plasma Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 63. Global Human Serum and Plasma Sales Quantity by Region (2020-2025) & (K Units)
Table 64. Global Human Serum and Plasma Sales Quantity by Region (2026-2031) & (K Units)
Table 65. Global Human Serum and Plasma Consumption Value by Region (2020-2025) & (USD Million)
Table 66. Global Human Serum and Plasma Consumption Value by Region (2026-2031) & (USD Million)
Table 67. Global Human Serum and Plasma Average Price by Region (2020-2025) & (US$/Unit)
Table 68. Global Human Serum and Plasma Average Price by Region (2026-2031) & (US$/Unit)
Table 69. Global Human Serum and Plasma Sales Quantity by Type (2020-2025) & (K Units)
Table 70. Global Human Serum and Plasma Sales Quantity by Type (2026-2031) & (K Units)
Table 71. Global Human Serum and Plasma Consumption Value by Type (2020-2025) & (USD Million)
Table 72. Global Human Serum and Plasma Consumption Value by Type (2026-2031) & (USD Million)
Table 73. Global Human Serum and Plasma Average Price by Type (2020-2025) & (US$/Unit)
Table 74. Global Human Serum and Plasma Average Price by Type (2026-2031) & (US$/Unit)
Table 75. Global Human Serum and Plasma Sales Quantity by Application (2020-2025) & (K Units)
Table 76. Global Human Serum and Plasma Sales Quantity by Application (2026-2031) & (K Units)
Table 77. Global Human Serum and Plasma Consumption Value by Application (2020-2025) & (USD Million)
Table 78. Global Human Serum and Plasma Consumption Value by Application (2026-2031) & (USD Million)
Table 79. Global Human Serum and Plasma Average Price by Application (2020-2025) & (US$/Unit)
Table 80. Global Human Serum and Plasma Average Price by Application (2026-2031) & (US$/Unit)
Table 81. North America Human Serum and Plasma Sales Quantity by Type (2020-2025) & (K Units)
Table 82. North America Human Serum and Plasma Sales Quantity by Type (2026-2031) & (K Units)
Table 83. North America Human Serum and Plasma Sales Quantity by Application (2020-2025) & (K Units)
Table 84. North America Human Serum and Plasma Sales Quantity by Application (2026-2031) & (K Units)
Table 85. North America Human Serum and Plasma Sales Quantity by Country (2020-2025) & (K Units)
Table 86. North America Human Serum and Plasma Sales Quantity by Country (2026-2031) & (K Units)
Table 87. North America Human Serum and Plasma Consumption Value by Country (2020-2025) & (USD Million)
Table 88. North America Human Serum and Plasma Consumption Value by Country (2026-2031) & (USD Million)
Table 89. Europe Human Serum and Plasma Sales Quantity by Type (2020-2025) & (K Units)
Table 90. Europe Human Serum and Plasma Sales Quantity by Type (2026-2031) & (K Units)
Table 91. Europe Human Serum and Plasma Sales Quantity by Application (2020-2025) & (K Units)
Table 92. Europe Human Serum and Plasma Sales Quantity by Application (2026-2031) & (K Units)
Table 93. Europe Human Serum and Plasma Sales Quantity by Country (2020-2025) & (K Units)
Table 94. Europe Human Serum and Plasma Sales Quantity by Country (2026-2031) & (K Units)
Table 95. Europe Human Serum and Plasma Consumption Value by Country (2020-2025) & (USD Million)
Table 96. Europe Human Serum and Plasma Consumption Value by Country (2026-2031) & (USD Million)
Table 97. Asia-Pacific Human Serum and Plasma Sales Quantity by Type (2020-2025) & (K Units)
Table 98. Asia-Pacific Human Serum and Plasma Sales Quantity by Type (2026-2031) & (K Units)
Table 99. Asia-Pacific Human Serum and Plasma Sales Quantity by Application (2020-2025) & (K Units)
Table 100. Asia-Pacific Human Serum and Plasma Sales Quantity by Application (2026-2031) & (K Units)
Table 101. Asia-Pacific Human Serum and Plasma Sales Quantity by Region (2020-2025) & (K Units)
Table 102. Asia-Pacific Human Serum and Plasma Sales Quantity by Region (2026-2031) & (K Units)
Table 103. Asia-Pacific Human Serum and Plasma Consumption Value by Region (2020-2025) & (USD Million)
Table 104. Asia-Pacific Human Serum and Plasma Consumption Value by Region (2026-2031) & (USD Million)
Table 105. South America Human Serum and Plasma Sales Quantity by Type (2020-2025) & (K Units)
Table 106. South America Human Serum and Plasma Sales Quantity by Type (2026-2031) & (K Units)
Table 107. South America Human Serum and Plasma Sales Quantity by Application (2020-2025) & (K Units)
Table 108. South America Human Serum and Plasma Sales Quantity by Application (2026-2031) & (K Units)
Table 109. South America Human Serum and Plasma Sales Quantity by Country (2020-2025) & (K Units)
Table 110. South America Human Serum and Plasma Sales Quantity by Country (2026-2031) & (K Units)
Table 111. South America Human Serum and Plasma Consumption Value by Country (2020-2025) & (USD Million)
Table 112. South America Human Serum and Plasma Consumption Value by Country (2026-2031) & (USD Million)
Table 113. Middle East & Africa Human Serum and Plasma Sales Quantity by Type (2020-2025) & (K Units)
Table 114. Middle East & Africa Human Serum and Plasma Sales Quantity by Type (2026-2031) & (K Units)
Table 115. Middle East & Africa Human Serum and Plasma Sales Quantity by Application (2020-2025) & (K Units)
Table 116. Middle East & Africa Human Serum and Plasma Sales Quantity by Application (2026-2031) & (K Units)
Table 117. Middle East & Africa Human Serum and Plasma Sales Quantity by Country (2020-2025) & (K Units)
Table 118. Middle East & Africa Human Serum and Plasma Sales Quantity by Country (2026-2031) & (K Units)
Table 119. Middle East & Africa Human Serum and Plasma Consumption Value by Country (2020-2025) & (USD Million)
Table 120. Middle East & Africa Human Serum and Plasma Consumption Value by Country (2026-2031) & (USD Million)
Table 121. Human Serum and Plasma Raw Material
Table 122. Key Manufacturers of Human Serum and Plasma Raw Materials
Table 123. Human Serum and Plasma Typical Distributors
Table 124. Human Serum and Plasma Typical Customers
LIST OF FIGURES
Figure 1. Human Serum and Plasma Picture
Figure 2. Global Human Serum and Plasma Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Human Serum and Plasma Revenue Market Share by Type in 2024
Figure 4. Fresh Human Serum and Plasma Examples
Figure 5. Frozen Human Serum and Plasma Examples
Figure 6. Global Human Serum and Plasma Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Human Serum and Plasma Revenue Market Share by Application in 2024
Figure 8. In Vitro Diagnostics Examples
Figure 9. Vaccines and Antibodies Examples
Figure 10. Cell Culture Examples
Figure 11. Clinical Research Examples
Figure 12. Others Examples
Figure 13. Global Human Serum and Plasma Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Human Serum and Plasma Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Human Serum and Plasma Sales Quantity (2020-2031) & (K Units)
Figure 16. Global Human Serum and Plasma Price (2020-2031) & (US$/Unit)
Figure 17. Global Human Serum and Plasma Sales Quantity Market Share by Manufacturer in 2024
Figure 18. Global Human Serum and Plasma Revenue Market Share by Manufacturer in 2024
Figure 19. Producer Shipments of Human Serum and Plasma by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 20. Top 3 Human Serum and Plasma Manufacturer (Revenue) Market Share in 2024
Figure 21. Top 6 Human Serum and Plasma Manufacturer (Revenue) Market Share in 2024
Figure 22. Global Human Serum and Plasma Sales Quantity Market Share by Region (2020-2031)
Figure 23. Global Human Serum and Plasma Consumption Value Market Share by Region (2020-2031)
Figure 24. North America Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 25. Europe Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 26. Asia-Pacific Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 27. South America Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 28. Middle East & Africa Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 29. Global Human Serum and Plasma Sales Quantity Market Share by Type (2020-2031)
Figure 30. Global Human Serum and Plasma Consumption Value Market Share by Type (2020-2031)
Figure 31. Global Human Serum and Plasma Average Price by Type (2020-2031) & (US$/Unit)
Figure 32. Global Human Serum and Plasma Sales Quantity Market Share by Application (2020-2031)
Figure 33. Global Human Serum and Plasma Revenue Market Share by Application (2020-2031)
Figure 34. Global Human Serum and Plasma Average Price by Application (2020-2031) & (US$/Unit)
Figure 35. North America Human Serum and Plasma Sales Quantity Market Share by Type (2020-2031)
Figure 36. North America Human Serum and Plasma Sales Quantity Market Share by Application (2020-2031)
Figure 37. North America Human Serum and Plasma Sales Quantity Market Share by Country (2020-2031)
Figure 38. North America Human Serum and Plasma Consumption Value Market Share by Country (2020-2031)
Figure 39. United States Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 40. Canada Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 41. Mexico Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 42. Europe Human Serum and Plasma Sales Quantity Market Share by Type (2020-2031)
Figure 43. Europe Human Serum and Plasma Sales Quantity Market Share by Application (2020-2031)
Figure 44. Europe Human Serum and Plasma Sales Quantity Market Share by Country (2020-2031)
Figure 45. Europe Human Serum and Plasma Consumption Value Market Share by Country (2020-2031)
Figure 46. Germany Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 47. France Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 48. United Kingdom Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 49. Russia Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 50. Italy Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 51. Asia-Pacific Human Serum and Plasma Sales Quantity Market Share by Type (2020-2031)
Figure 52. Asia-Pacific Human Serum and Plasma Sales Quantity Market Share by Application (2020-2031)
Figure 53. Asia-Pacific Human Serum and Plasma Sales Quantity Market Share by Region (2020-2031)
Figure 54. Asia-Pacific Human Serum and Plasma Consumption Value Market Share by Region (2020-2031)
Figure 55. China Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 56. Japan Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 57. South Korea Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 58. India Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 59. Southeast Asia Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 60. Australia Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 61. South America Human Serum and Plasma Sales Quantity Market Share by Type (2020-2031)
Figure 62. South America Human Serum and Plasma Sales Quantity Market Share by Application (2020-2031)
Figure 63. South America Human Serum and Plasma Sales Quantity Market Share by Country (2020-2031)
Figure 64. South America Human Serum and Plasma Consumption Value Market Share by Country (2020-2031)
Figure 65. Brazil Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 66. Argentina Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 67. Middle East & Africa Human Serum and Plasma Sales Quantity Market Share by Type (2020-2031)
Figure 68. Middle East & Africa Human Serum and Plasma Sales Quantity Market Share by Application (2020-2031)
Figure 69. Middle East & Africa Human Serum and Plasma Sales Quantity Market Share by Country (2020-2031)
Figure 70. Middle East & Africa Human Serum and Plasma Consumption Value Market Share by Country (2020-2031)
Figure 71. Turkey Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 72. Egypt Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 73. Saudi Arabia Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 74. South Africa Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 75. Human Serum and Plasma Market Drivers
Figure 76. Human Serum and Plasma Market Restraints
Figure 77. Human Serum and Plasma Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Human Serum and Plasma in 2024
Figure 80. Manufacturing Process Analysis of Human Serum and Plasma
Figure 81. Human Serum and Plasma Industrial Chain
Figure 82. Sales Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Figure 1. Human Serum and Plasma Picture
Figure 2. Global Human Serum and Plasma Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Human Serum and Plasma Revenue Market Share by Type in 2024
Figure 4. Fresh Human Serum and Plasma Examples
Figure 5. Frozen Human Serum and Plasma Examples
Figure 6. Global Human Serum and Plasma Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Human Serum and Plasma Revenue Market Share by Application in 2024
Figure 8. In Vitro Diagnostics Examples
Figure 9. Vaccines and Antibodies Examples
Figure 10. Cell Culture Examples
Figure 11. Clinical Research Examples
Figure 12. Others Examples
Figure 13. Global Human Serum and Plasma Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Human Serum and Plasma Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Human Serum and Plasma Sales Quantity (2020-2031) & (K Units)
Figure 16. Global Human Serum and Plasma Price (2020-2031) & (US$/Unit)
Figure 17. Global Human Serum and Plasma Sales Quantity Market Share by Manufacturer in 2024
Figure 18. Global Human Serum and Plasma Revenue Market Share by Manufacturer in 2024
Figure 19. Producer Shipments of Human Serum and Plasma by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 20. Top 3 Human Serum and Plasma Manufacturer (Revenue) Market Share in 2024
Figure 21. Top 6 Human Serum and Plasma Manufacturer (Revenue) Market Share in 2024
Figure 22. Global Human Serum and Plasma Sales Quantity Market Share by Region (2020-2031)
Figure 23. Global Human Serum and Plasma Consumption Value Market Share by Region (2020-2031)
Figure 24. North America Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 25. Europe Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 26. Asia-Pacific Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 27. South America Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 28. Middle East & Africa Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 29. Global Human Serum and Plasma Sales Quantity Market Share by Type (2020-2031)
Figure 30. Global Human Serum and Plasma Consumption Value Market Share by Type (2020-2031)
Figure 31. Global Human Serum and Plasma Average Price by Type (2020-2031) & (US$/Unit)
Figure 32. Global Human Serum and Plasma Sales Quantity Market Share by Application (2020-2031)
Figure 33. Global Human Serum and Plasma Revenue Market Share by Application (2020-2031)
Figure 34. Global Human Serum and Plasma Average Price by Application (2020-2031) & (US$/Unit)
Figure 35. North America Human Serum and Plasma Sales Quantity Market Share by Type (2020-2031)
Figure 36. North America Human Serum and Plasma Sales Quantity Market Share by Application (2020-2031)
Figure 37. North America Human Serum and Plasma Sales Quantity Market Share by Country (2020-2031)
Figure 38. North America Human Serum and Plasma Consumption Value Market Share by Country (2020-2031)
Figure 39. United States Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 40. Canada Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 41. Mexico Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 42. Europe Human Serum and Plasma Sales Quantity Market Share by Type (2020-2031)
Figure 43. Europe Human Serum and Plasma Sales Quantity Market Share by Application (2020-2031)
Figure 44. Europe Human Serum and Plasma Sales Quantity Market Share by Country (2020-2031)
Figure 45. Europe Human Serum and Plasma Consumption Value Market Share by Country (2020-2031)
Figure 46. Germany Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 47. France Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 48. United Kingdom Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 49. Russia Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 50. Italy Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 51. Asia-Pacific Human Serum and Plasma Sales Quantity Market Share by Type (2020-2031)
Figure 52. Asia-Pacific Human Serum and Plasma Sales Quantity Market Share by Application (2020-2031)
Figure 53. Asia-Pacific Human Serum and Plasma Sales Quantity Market Share by Region (2020-2031)
Figure 54. Asia-Pacific Human Serum and Plasma Consumption Value Market Share by Region (2020-2031)
Figure 55. China Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 56. Japan Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 57. South Korea Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 58. India Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 59. Southeast Asia Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 60. Australia Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 61. South America Human Serum and Plasma Sales Quantity Market Share by Type (2020-2031)
Figure 62. South America Human Serum and Plasma Sales Quantity Market Share by Application (2020-2031)
Figure 63. South America Human Serum and Plasma Sales Quantity Market Share by Country (2020-2031)
Figure 64. South America Human Serum and Plasma Consumption Value Market Share by Country (2020-2031)
Figure 65. Brazil Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 66. Argentina Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 67. Middle East & Africa Human Serum and Plasma Sales Quantity Market Share by Type (2020-2031)
Figure 68. Middle East & Africa Human Serum and Plasma Sales Quantity Market Share by Application (2020-2031)
Figure 69. Middle East & Africa Human Serum and Plasma Sales Quantity Market Share by Country (2020-2031)
Figure 70. Middle East & Africa Human Serum and Plasma Consumption Value Market Share by Country (2020-2031)
Figure 71. Turkey Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 72. Egypt Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 73. Saudi Arabia Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 74. South Africa Human Serum and Plasma Consumption Value (2020-2031) & (USD Million)
Figure 75. Human Serum and Plasma Market Drivers
Figure 76. Human Serum and Plasma Market Restraints
Figure 77. Human Serum and Plasma Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Human Serum and Plasma in 2024
Figure 80. Manufacturing Process Analysis of Human Serum and Plasma
Figure 81. Human Serum and Plasma Industrial Chain
Figure 82. Sales Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
